Phentolamine

From WikiMD's WELLNESSPEDIA


Phentolamine
Phentolamine Structural Formulae.svg
INN
Drug class
Routes of administration Intravenous, Intramuscular, Intracavernosal
Pregnancy category
Bioavailability
Metabolism Liver
Elimination half-life ~19 minutes
Excretion Urine
Legal status
CAS Number 50-60-2
PubChem 4757
DrugBank DB00692
ChemSpider
KEGG


Phentolamine (brand names: Regitine, OraVerse) is a nonselective alpha-adrenergic antagonist used primarily in the management of hypertensive emergencies, pheochromocytoma, and erectile dysfunction.[1] It works by blocking alpha receptors, leading to vasodilation and a subsequent decrease in blood pressure.

Mechanism of Action[edit]

Phentolamine acts as a competitive, reversible alpha-adrenergic antagonist, blocking both α1 and α2 receptors:

  • α1 receptor blockade: Causes vasodilation, reducing vascular resistance and blood pressure.[2]
  • α2 receptor blockade: Inhibits negative feedback on norepinephrine release, leading to increased sympathetic activity, which may cause reflex tachycardia.[3]

Therapeutic Uses[edit]

Phentolamine is utilized in various clinical scenarios, including:

1. Hypertensive Emergencies[edit]

  • Used in pheochromocytoma crises to rapidly lower blood pressure.[4]
  • Preferred in cocaine-induced hypertension, where beta-blockers are contraindicated to avoid unopposed α-adrenergic stimulation.

2. Pheochromocytoma Treatment[edit]

  • Administered before beta-blockers to prevent hypertensive crises.

3. Erectile Dysfunction (ED)[edit]

  • When injected intracavernosally, phentolamine increases penile blood flow, aiding erection induction.[5]

4. Peripheral Vasoconstriction Reversal[edit]

  • Used in cases of extravasation of vasopressors (e.g., norepinephrine, dopamine), preventing tissue necrosis.

5. Complex Regional Pain Syndrome (CRPS)[edit]

  • Phentolamine infusion can help diagnose and manage CRPS (Reflex Sympathetic Dystrophy).[6]

6. Local Anesthetic Reversal[edit]

  • Marketed as OraVerse, phentolamine is used in dentistry to reverse local anesthetic effects, restoring normal sensation more quickly.[7]

Chemical Synthesis[edit]

Phentolamine's full chemical name is 2-[[N-(3′-hydroxyphenyl)-para-toluidino]methyl]-2-imidazoline.

Its synthesis involves: 1. Alkylation of 3-(4-methylanilino)phenol. 2. Reaction with 2-chloromethylimidazoline.

File:Phentolamine synthesis.png

Patent and Research[edit]

  • K. Miescher, A. Marxer, E. Urech, U.S. patent 2,503,059 (1950).
  • E. Urech, A. Marxer, K. Miescher, Helv. Chim. Acta, 33, 1386 (1950).

Pharmacokinetics[edit]

  • Absorption: Rapid onset (IV: ~2 minutes)
  • Half-life: ~19 minutes
  • Metabolism: Liver (hepatic enzymatic degradation)
  • Excretion: Primarily in urine

Adverse Effects[edit]

Common side effects include:

  • Hypotension (low blood pressure)
  • Reflex tachycardia
  • Dizziness, flushing
  • Nasal congestion (due to vasodilation)

Serious adverse effects:

  • Severe hypotension
  • Arrhythmias
  • Myocardial ischemia (rare)

Contraindications[edit]

Phentolamine should not be used in:

  • Myocardial infarction (increases cardiac workload)
  • Coronary artery disease
  • Severe hypotension
  • Hypersensitivity to phentolamine

Drug Interactions[edit]

  • Beta-blockers – Risk of unopposed α-adrenergic effects.
  • Vasodilators (e.g., nitroglycerin, hydralazine) – Additive hypotensive effect.
  • Sympathomimetics (e.g., epinephrine) – Can lead to unpredictable blood pressure responses.

See Also[edit]







  1. {{{last}}}, Jewell, John R.; Longworth, David L.; Stoller, James K.; Casey, David, The Cleveland Clinic Internal Medicine Case Reviews, Lippincott Williams & Wilkins, 2003, ISBN 0-7817-4266-8,
  2. Brock G. Oral phentolamine (Vasomax). Drugs Today (Barcelona). 2000 Feb-Mar;36(2-3):121-4.
  3. {{{last}}}, Shen, Howard, Illustrated Pharmacology Memory Cards: PharMnemonics, Minireview, 2008, ISBN 1-59541-101-1,
  4. Tuncel M, Ram VC. Hypertensive emergencies. American Journal of Cardiovascular Drugs. 2003;3(1):21-31.
  5. Bella AJ, Brock GB. Intracavernous pharmacotherapy for erectile dysfunction. Endocrine. 2004 Mar-Apr;23(2-3):149-55.
  6. Rowbotham MC. Pharmacologic management of complex regional pain syndrome. Clinical Journal of Pain. 2006 Jun;22(5):425-9.
  7. http://www.novalar.com/oraverse-dental-specialty-pharmaceutical